Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,017 | -1,306 | -738 | -50,860 | -36,956 |
| Depreciation Amortization | 21 | 14 | 7 | 324 | 245 |
| Accounts payable and accrued liabilities | 244 | 172 | 16 | 898 | -524 |
| Other Working Capital | 425 | 420 | 319 | 3,075 | 172 |
| Other Operating Activity | 74 | -120 | -9 | 5,866 | 5,606 |
| Operating Cash Flow | $-1,252 | $-820 | $-404 | $-40,697 | $-31,457 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -189 | -161 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-189 | $-161 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,000 | 5,000 |
| Debt Repayment | -11 | -7 | -4 | N/A | N/A |
| Common Stock Issued | 1,229 | 1,056 | 1,056 | 17,554 | 17,526 |
| Financing Cash Flow | $1,219 | $1,049 | $1,053 | $22,554 | $22,526 |
| Beginning Cash Position | 176 | 176 | 176 | 106,399 | 106,399 |
| End Cash Position | 143 | 405 | 824 | 88,068 | 97,307 |
| Net Cash Flow | $-33 | $229 | $648 | $-18,331 | $-9,092 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,252 | -820 | -404 | -40,697 | -31,457 |
| Capital Expenditure | N/A | N/A | N/A | -189 | -161 |
| Free Cash Flow | -1,252 | -820 | -404 | -40,886 | -31,618 |